Johnson & Johnson says it plans to have more than half a billion vaccines ready for coronavirus early next year.
Chief Financial Officer Joe Wolk said Tuesday that the pharmaceutical giant will have 600 million to 800 million vaccines available in early 2021, when it expects the US government to approve the medication it plans to start testing in humans this September.
“The timeframe is still fairly certain,” Wolk said during an interview with Yahoo Finance. “We are manufacturing at risk to ensure that we are in a position to turn the switch and ready to go to build great access across the globe if clinical research and trials are successful.”
The business aims to scale up production by the end of next year to 1 billion doses annually, Wolk said in the interview. Last month, J&J and the Federal Biomedical Advanced Research and Development Authority reported an investment of 1 billion dollars to help achieve that objective.
J&J plans to set up a new US manufacturing facility to replace the Dutch company’s plant which can manufacture up to 300 million doses. The factory on the stateside will be up and running later this or early next year, Wolk told Yahoo. Read More